HopeStage
Back to all studies
CompletedNCT00301210

Tramadol for opioid dependence

About this titleRead the official source — NCT00301210
Medication studyAges 21–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 55 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2006
Recruitment status
Completed
Enrollment listed in the registry
9
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT00301210
Official title
Show the full official title

Assessment of the Level of Physical Dependence and Blockade Efficacy Produced by Tramadol

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including Tramadol.

Who was this study for?

Listed age limits: 21 years to 55 years.

Want to explore more studies?

Explore studies